Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;57(6):2892-5.
doi: 10.1128/AAC.00274-13. Epub 2013 Apr 9.

Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins

Kenneth S Thomson  1 , Richard V Goering
Affiliations

Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins

Kenneth S Thomson et al. Antimicrob Agents Chemother. 2013 Jun.

Abstract

The in vitro activities of tedizolid and 10 antistaphylococcal agents were compared against 111 methicillin-resistant Staphylococcus aureus (MRSA) strains from 14 epidemiologically characterized groups. Tedizolid, tigecycline, and daptomycin were the most potent agents, with tedizolid 4-fold more potent than linezolid. Tedizolid, linezolid, and vancomycin were unaffected by epidemiological types. Tigecycline and daptomycin had reduced potency against ST80-MRSA-IV and ST239-MRSA-III, respectively. Overall, tedizolid was highly potent against all MRSA strain types, including those resistant to other classes of drugs.

PubMed Disclaimer

References

    1. Ratnaraja NV, Hawkey PM. 2008. Current challenges in treating MRSA: what are the options? Expert Rev. Anti Infect. Ther. 6:601–618 - PubMed
    1. Dulon M, Haamann F, Peters C, Schablon A, Nienhaus A. 2011. MRSA prevalence in European healthcare settings: a review. BMC Infect. Dis. 11:138 doi:10.1186/1471-2334-11-138 - DOI - PMC - PubMed
    1. Yanagihara K, Kaneko Y, Sawai T, Miyazaki Y, Tsukamoto K, Hirakata Y, Tomono K, Kadota J, Tashiro T, Murata I, Kohno S. 2002. Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection. Antimicrob. Agents Chemother. 46:3288–3291 - PMC - PubMed
    1. Brown SD, Traczewski MM. 2010. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Antimicrob. Agents Chemother. 54:2063–2069 - PMC - PubMed
    1. Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ. 2012. In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci. J. Antimicrob. Chemother. 67:167–169 - PubMed

Publication types

MeSH terms

LinkOut - more resources